Works matching AU Kao, Jia‐Horng


Results: 197
    1
    2
    3
    4
    5

    Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study.

    Published in:
    Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-32060-7
    By:
    • Liu, Chen-Hua;
    • Huang, Yi-Jie;
    • Yang, Sien-Sing;
    • Chang, Chung-Hsin;
    • Yang, Sheng-Shun;
    • Sun, Hsin-Yun;
    • Liu, Chun-Jen;
    • Liu, Wen-Chun;
    • Su, Tung-Hung;
    • Yang, Hung-Chih;
    • Hong, Chun-Ming;
    • Tseng, Tai-Chung;
    • Chen, Pei-Jer;
    • Chen, Ding-Shinn;
    • Hung, Chien-Ching;
    • Kao, Jia-Horng
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study.

    Published in:
    Open Forum Infectious Diseases, 2022, v. 9, n. 8, p. 1, doi. 10.1093/ofid/ofac348
    By:
    • Liu, Chen-Hua;
    • Sun, Hsin-Yun;
    • Peng, Cheng-Yuan;
    • Hsieh, Szu-Min;
    • Yang, Sheng-Shun;
    • Kao, Wei-Yu;
    • Shih, Yu-Lueng;
    • Lin, Chih-Lin;
    • Liu, Chun-Jen;
    • Sheng, Wang-Hui;
    • Lo, Yi-Chun;
    • Liu, Wen-Chun;
    • Wu, Jo-Hsuan;
    • Su, Tung-Hung;
    • Tseng, Tai-Chung;
    • Chen, Pei-Jer;
    • Hung, Chien-Ching;
    • Kao, Jia-Horng
    Publication type:
    Article
    19
    21

    Risk of Incident Type 2 Diabetes and Prediabetes in Patients With Direct Acting Antiviral‐Induced Cure of Hepatitis C Virus Infection.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 9, p. 1508, doi. 10.1111/apt.70029
    By:
    • Chang, Yu‐Ping;
    • Lee, Ji‐Yuh;
    • Chen, Chi‐Yi;
    • Kao, Wei‐Yu;
    • Lin, Chih‐Lin;
    • Yang, Sheng‐Shun;
    • Shih, Yu‐Lueng;
    • Peng, Cheng‐Yuan;
    • Lee, Fu‐Jen;
    • Tsai, Ming‐Chang;
    • Huang, Shang‐Chin;
    • Su, Tung‐Hung;
    • Tseng, Tai‐Chung;
    • Liu, Chun‐Jen;
    • Chen, Pei‐Jer;
    • Kao, Jia‐Horng;
    • Liu, Chen‐Hua
    Publication type:
    Article
    22
    23
    24

    Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatment.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 4, p. 434, doi. 10.1111/apt.16697
    By:
    • Liu, Chen‐Hua;
    • Peng, Cheng‐Yuan;
    • Kao, Wei‐Yu;
    • Yang, Sheng‐Shun;
    • Shih, Yu‐Lueng;
    • Lin, Chin‐Lin;
    • Tsai, Meng‐Kun;
    • Lee, Chih‐Yuan;
    • Chang, Chun‐Chao;
    • Wu, Jo‐Hsuan;
    • Liu, Chun‐Jen;
    • Su, Tung‐Hung;
    • Tseng, Tai‐Chung;
    • Chen, Pei‐Jer;
    • Kao, Jia‐Horng
    Publication type:
    Article
    25
    26
    27
    28
    29

    East Asia expert opinion on treatment initiation for chronic hepatitis B.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 10, p. 1540, doi. 10.1111/apt.16097
    By:
    • Kao, Jia‐Horng;
    • Hu, Tsung‐Hui;
    • Jia, Jidong;
    • Kurosaki, Masayuki;
    • Lim, Young‐Suk;
    • Lin, Han‐Chieh;
    • Sinn, Dong Hyun;
    • Tanaka, Yasuhito;
    • Wai‐Sun Wong, Vincent;
    • Yuen, Man‐Fung
    Publication type:
    Article
    30
    31
    33
    34
    35
    37

    Comorbidities, concomitant medications and potential drug‐drug interactions with interferon‐free direct‐acting antiviral agents in hepatitis C patients in Taiwan.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 11/12, p. 1290, doi. 10.1111/apt.15011
    By:
    • Liu, Chen‐Hua;
    • Yu, Ming‐Lung;
    • Peng, Cheng‐Yuan;
    • Hsieh, Tsai‐Yuan;
    • Huang, Yi‐Hsiang;
    • Su, Wei‐Wen;
    • Cheng, Pin‐Nan;
    • Lin, Chih‐Lin;
    • Lo, Ching‐Chu;
    • Chen, Chi‐Yi;
    • Chen, Jyh‐Jou;
    • Ma, Qian;
    • Brooks‐Rooney, Craig;
    • Kao, Jia‐Horng
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50